Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
---|
10/31/2002 | WO2002085403A1 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5 |
10/31/2002 | WO2002085395A1 Total glycosides of paeony, method to prepare the same and uses thereof |
10/31/2002 | WO2002085359A1 Agent for topical ophthalmic treatment of ocular inflammatory diseases |
10/31/2002 | WO2001052746A9 Versatile hydrophilic dyes |
10/31/2002 | US20020161221 Ether type lipid a 1-carboxylic acid analogs |
10/31/2002 | US20020161206 For inhibiting tumor cell growth |
10/31/2002 | US20020160964 Conjugates comprising galactose alpha 1,3 galactosyl epitopes and methods of using same |
10/31/2002 | CA2445508A1 Agent for topical ophthalmic treatment of ocular inflammatory diseases |
10/31/2002 | CA2444907A1 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5 |
10/31/2002 | CA2444055A1 Bacteriotoxin adsorbents and method of screening the same |
10/30/2002 | EP1252171A1 Method for preparing functionalised beta-(1,3)-glucan derivatives |
10/30/2002 | EP1252133A2 Pharmaceutical compounds |
10/30/2002 | EP1251859A1 Novel compounds |
10/30/2002 | EP1090017B1 Novel compounds derived from alpha-d-xylose, preparation method and therapeutic use |
10/29/2002 | US6473512 Apparatus and method for a custom soft-solid hearing aid |
10/29/2002 | US6472158 Ustilipides, method for the production and the use thereof |
10/29/2002 | CA2088128C Salts of glucopyranose derivatives and its intermediate |
10/29/2002 | CA2014486C Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyltrithio group |
10/24/2002 | WO2002083067A2 Prodrugs via acylation with cinnamate |
10/24/2002 | WO2002083066A2 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
10/24/2002 | WO2000039137A3 Regiospecific synthesis of glucose-based surfactants |
10/24/2002 | US20020156117 Receptor-avid exogenous optical contrast and therapeutic agents |
10/24/2002 | US20020156022 Compounds and methods for treating transplant rejection |
10/24/2002 | US20020155999 Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer |
10/24/2002 | US20020155565 FAP-activated anti-tumor compounds |
10/24/2002 | US20020155094 Method of treating sepsis and ARDS using chemokine beta-9 |
10/24/2002 | CA2444481A1 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
10/24/2002 | CA2444264A1 Prodrugs via acylation with cinnamate |
10/23/2002 | EP1250333A1 Dendrimer precursor dyes for imaging |
10/23/2002 | EP1250141A1 Prevention and treatment of endotoxemia and related complications associated with surgery |
10/23/2002 | EP1250095A1 Versatile hydrophilic dyes |
10/23/2002 | CN1376158A Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them |
10/23/2002 | CN1375499A Method of extracting and separating several components from mangsteen |
10/22/2002 | US6469148 Of high isomeric purity, includes reacting a benzaldehyde, zinc chloride solution with galactose, filtering, diluting filtrate with organic solvent, extracting with cold water and ion exchanging to remove zinc ions |
10/22/2002 | US6468939 Esters of phosphoric acid, phosphorous acid, phosphonic acid, phosphonous acid, phosphinic acid or phosphinous acid; complexing ligands |
10/22/2002 | CA2227264C Amine acid salt compounds and process for the production thereof |
10/22/2002 | CA2040437C Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor |
10/17/2002 | WO2002081491A2 New genistein derivatives and pharmaceutical preparations containing them |
10/17/2002 | WO2002081483A2 Inhibitors of acyl glucosaminyl inositol amidase and methods of use |
10/17/2002 | WO2002081480A1 Compounds and pharmaceutical compositions for inhibiting mrp1 |
10/17/2002 | WO2002081466A1 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
10/17/2002 | WO2002080936A1 Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
10/17/2002 | WO2002032860A3 Dynamic organ function monitoring agents |
10/17/2002 | US20020151505 Treatment of helicobacter with isothiocyanates |
10/17/2002 | US20020150936 Biosynthesis of 2'-O-silyl-nucleoside phosphoramidite; obtain nucleoside, incubate with silyl compound, desilylate, incubate with phosphoramidate, recover nucleoside phosphoramidate |
10/17/2002 | CA2442141A1 Compounds and pharmaceutical compositions for inhibiting mrp1 |
10/16/2002 | EP1248761A1 Compounds which mimic the chemical and biological properties of discodermolide |
10/16/2002 | EP1248629A1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
10/16/2002 | EP0948509B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
10/16/2002 | EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use |
10/16/2002 | CN1374969A FAP-activated anti-tumor compounds |
10/15/2002 | US6465625 Taxol derivatives |
10/10/2002 | WO2002079213A1 Process for the preparation of 2'-halo-$g(b)-l-arabinofuranosyl nucleosides |
10/10/2002 | WO2002079150A2 Glycorandomization and the production of novel erythronolide and coumarin analogs |
10/10/2002 | WO2002078597A2 Oral absorbed drugs |
10/10/2002 | WO2002051862A3 Cytostatic-glycoconjugates having specifically cleavable peptidiclinking units |
10/10/2002 | US20020147353 Drugs; oxidaton resistance |
10/10/2002 | US20020146390 Therapy of sepsis and adult respiratory distress syndrome using chemokine or biologically active fragment thereof, alone or in conjunction with an anti-infective agent |
10/09/2002 | EP1246826A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
10/09/2002 | EP1129208B1 Vancoresmycin, a process for its production and its use as a pharmaceutical |
10/08/2002 | US6462191 Synthesis of 2-deoxy-2-fluoro-arabinose derivatives |
10/08/2002 | US6462183 Protected aminosugars |
10/08/2002 | US6462182 Chemotherapy, microbial infections; enhanced solubility; catalysis, hydrolysis |
10/03/2002 | WO2002077255A1 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles |
10/03/2002 | WO2002077004A1 Synthetic derivatives of 21-butenyl and related spinosyns |
10/03/2002 | WO2002076448A1 Molecular conjugates for use in treatment of cancer |
10/03/2002 | WO2002076402A2 Fatty amine drug conjugates |
10/03/2002 | WO2002030942A3 Anhydro sugar derivatives of indolocarbazoles |
10/03/2002 | US20020141972 Administering protein and antiinflection agent |
10/03/2002 | CA2441484A1 Molecular conjugates for use in treatment of cancer |
10/03/2002 | CA2441412A1 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles |
10/02/2002 | EP1244417A1 Use of alkyl- and/or alkenyloligoglycoside fatty acid esters for improving the sensory evaluation of emulsions |
10/02/2002 | EP0843675B1 Aza-anthracyclinone derivatives |
10/02/2002 | DE10111682A1 Caloporosid-Derivate, Verfahren zu deren Herstellung und deren Verwendung Caloporoside derivatives, processes for their preparation and their use |
10/02/2002 | CN1371690A Vaccine composition for initiating anti-N-glycolyl ganglioside immunoreaction and application thereof |
10/02/2002 | CN1091791C 钻井液 Drilling |
10/02/2002 | CN1091773C Process for preparing yam saponin |
10/02/2002 | CN1091604C Processed ginseng extract having enhanced pharmacological offset and preparation method |
10/01/2002 | US6458937 Glycoconjugates and methods |
10/01/2002 | US6458401 Process for producing a powder containing crystalline particles of maltitol |
10/01/2002 | CA2235943C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
09/26/2002 | WO2002074737A2 Process for the preparation of 2-hydroxymethyl-pyrolidine-3,4-diols |
09/26/2002 | WO2000064917A3 Synthetic indolocarbazole regioisomers and uses thereof |
09/26/2002 | US20020137903 Sodium dependent glucose transporters found in the intestine and kidney (SGLT2); treating diabetes |
09/26/2002 | US20020137694 Methods and compositions for the manufacture of C-3' and C-4' anthracycline antibiotics |
09/26/2002 | US20020137690 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
09/25/2002 | EP1243652A2 Glial derived neurotrophic factor |
09/25/2002 | EP1242438A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
09/25/2002 | EP1242435A2 Medicaments for treatment of respiratory syncytial virus infections |
09/25/2002 | EP1242420A2 Agents and methods for the treatment of proliferative diseases |
09/25/2002 | EP1242110A1 A method and composition for treating prostate cancer |
09/25/2002 | EP1064293B1 Crystallization of lactitol, crystalline lactitol product and use thereof |
09/25/2002 | EP0912613B1 Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same |
09/25/2002 | EP0751948B1 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
09/25/2002 | CN1091447C 4,7-dialkoxy-N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses inclinical specimens |
09/25/2002 | CN1091446C Colchicine derivatives, use thereof and formulations containing them |
09/24/2002 | US6455572 Estrogen agonist/antagonist metabolites |
09/19/2002 | WO2002072593A2 Alkylated c-sugars and uses thereof |
09/19/2002 | WO2002072110A1 Caloporoside derivatives, methods for the production thereof and their use |
09/19/2002 | US20020132310 Derivatized reduced malto-oligosaccharides |